Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_830546519f5f26ac1c4c6d577378e060 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
filingDate |
2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_908ee65dbb21eb9a4c4e6e8e15492433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7a3eb23af042cc5801b52203dfff4aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e02bb3dc5340d8cb10b451cd0dfbcb32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cbf4fa548d6ddd0bdfe4359ff411487 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9f40485e9fc4d351b33e6d93be6e14e |
publicationDate |
2010-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2393472-C1 |
titleOfInvention |
Diagnostic technique for clear cell renal adenocarcinoma and set for implementation thereof |
abstract |
FIELD: medicine. n SUBSTANCE: there is offered a diagnostic technique for clear cell renal carcinoma (CCRC). The varied concentration of mRNA of CALL gene is used as a marker. The reduced mRNA in a presumptively involved tissue in comparison with that in a healthy tissue is a diagnostic character of CCRC. n EFFECT: invention allows for high-reliable diagnosis of CCRC, including early-staged. n 7 cl, 6 ex, 4 tbl, 2 dwg |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2605829-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2545998-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2545995-C2 |
priorityDate |
2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |